Market Place
Sourcing Support
Certara Reports Q3 2024 Financial Results
06 Nov 2024 //
GLOBENEWSWIRE
Certara to Participate in the Stephens Annual Investment Conference
28 Oct 2024 //
#N/A
Certara Appoints John Reynders as New Independent Board Member
16 Oct 2024 //
GLOBENEWSWIRE
Certara To Report Q3 2024 Results On November 6th
09 Oct 2024 //
GLOBENEWSWIRE
Certara Completes Acquisition of Chemaxon
03 Oct 2024 //
GLOBENEWSWIRE
Certara’s Simcyp Consortium Celebrates 25th Anniversary
24 Sep 2024 //
GLOBENEWSWIRE
Certara & Ichnos Optimize Cancer Drug Dosing Strategy
18 Sep 2024 //
GLOBENEWSWIRE
Certara to Participate in Upcoming Investor Conferences
21 Aug 2024 //
GLOBENEWSWIRE
Certara Launches Phoenix™ Version 8.5 Drug Development Software
15 Aug 2024 //
GLOBENEWSWIRE
Certara Reports Second Quarter 2024 Financial Results
06 Aug 2024 //
GLOBENEWSWIRE
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
09 Jul 2024 //
GLOBENEWSWIRE
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
02 Jul 2024 //
GLOBENEWSWIRE
Certara Launches CoAuthor™ Generative AI Regulatory Writing Software
17 Jun 2024 //
GLOBENEWSWIRE
Certara to Participate in the Jefferies Global Healthcare Conference
29 May 2024 //
GLOBENEWSWIRE
Certara Appoints New Chief Human Resources Officer & General Counsel
21 May 2024 //
GLOBENEWSWIRE
Certara & Cloudscientific accelerate AI for drug development in China
14 May 2024 //
BIOSPECTRUM ASIA
Certara Reports First Quarter 2024 Financial Results
06 May 2024 //
GLOBENEWSWIRE
Certara Launches Cloud Platform to Unify Its Scientific Software Portfolio
16 Apr 2024 //
GLOBENEWSWIRE
Certara: Q1 2024 Results on May 7, BofA Conference
09 Apr 2024 //
GLOBENEWSWIRE
Certara Reports Fourth Quarter 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Certara to Report Fourth Quarter and Full Year 2023 Financial Results
01 Feb 2024 //
GLOBENEWSWIRE
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio
13 Dec 2023 //
GLOBENEWSWIRE
Certara introduces Simcyp Biopharmaceutics software
21 Nov 2023 //
GLOBENEWSWIRE
Certara Reports Third Quarter 2023 Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
Certara to Report Third Quarter 2023 Financial Results
11 Oct 2023 //
GLOBENEWSWIRE
Certara Announces 300th Regulatory Submission Milestone Using its Software
19 Sep 2023 //
GLOBENEWSWIRE
Certara Simcypâ„¢ Group Awarded Two New Grants from US FDA
29 Aug 2023 //
GLOBENEWSWIRE
Certara to Participate in Upcoming Investor Conferences
29 Aug 2023 //
GLOBENEWSWIRE
Certara Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset
03 Aug 2023 //
BUSINESSWIRE
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
13 Jul 2023 //
GLOBENEWSWIRE
Certara to Participate in the Jefferies Global Healthcare Conference
02 Jun 2023 //
GLOBENEWSWIRE
Certara Reports First Quarter 2023 Financial Results
08 May 2023 //
GLOBENEWSWIRE
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals
27 Apr 2023 //
GLOBENEWSWIRE
Certara to Report First Quarter 2023 Financial Results on May 8th, 2023
10 Apr 2023 //
GLOBENEWSWIRE
A.I. Coming to Certara D360 Scientific Informatics Software
09 Mar 2023 //
GLOBENEWSWIRE
Certara announces the release of Simcyp PBPK Simulator Version 22
07 Mar 2023 //
GLOBENEWSWIRE
Certara Announces Transition Plan for Chief Financial Officer
01 Mar 2023 //
GLOBENEWSWIRE
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
01 Mar 2023 //
GLOBENEWSWIRE
Certara to Participate in the Barclays Global Healthcare Conference
27 Feb 2023 //
GLOBENEWSWIRE
Certara to Report Fourth Quarter and Full Year 2022 Financial Results
01 Feb 2023 //
GLOBENEWSWIRE
Certara Acquires Vyasa, an Artificial Intelligence Company
04 Jan 2023 //
GLOBENEWSWIRE
Certara Announces the Completion of Arsenal Capital Partners’ Investment
08 Dec 2022 //
GLOBENEWSWIRE
Certara Reports Third Quarter 2022 Financial Results
07 Nov 2022 //
GLOBENEWSWIRE
PMDA Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
19 Oct 2022 //
GLOBENEWSWIRE
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
13 Oct 2022 //
GLOBENEWSWIRE
Certara Announces Secondary Offering
11 Aug 2022 //
GLOBENEWSWIRE
Certara Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
Certara Introduces Update of Pinnacle 21 Enterprise and New Pinnacle 21 Data
05 Aug 2022 //
GLOBENEWSWIRE
Certara Appoints Rosemary Crane as New Independent Board Member
25 Jul 2022 //
GLOBENEWSWIRE
Certara Appoints Eran Broshy as New Independent Board Member
13 Jul 2022 //
GLOBENEWSWIRE
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
12 Jul 2022 //
GLOBENEWSWIRE
Certara Introduces New Simcyp Discovery Simulator for Drug Development
28 Jun 2022 //
GLOBENEWSWIRE
Certara Announces New Versions of Biosimulation Software for Novel Biologics
21 Jun 2022 //
GLOBENEWSWIRE
Certara Reports First Quarter 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
Certara to Participate in Upcoming Investor Conferences
03 May 2022 //
GLOBENEWSWIRE
Certara Reports Q4 and Full Year 2021 Financial Results
01 Mar 2022 //
GLOBENEWSWIRE
U.S. FDA Licenses Certara`s Immunogenicity Simulator
23 Feb 2022 //
GLOBENEWSWIRE
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software
21 Dec 2021 //
GLOBENEWSWIRE
Certara Announces Release of Simcyp™ Simulator V21, Expanding Capabilities
02 Dec 2021 //
GLOBENEWSWIRE
